SavedAdd your journal

Journals / Klinik Psikofarmakoloji Bülteni / 2012 / Cilt: 22 - Sayı: 3

Metilfenidat ile olası ilişkili ses kısıklığı ve ses kalitesinde bozulma: İki çocuk olgu

Possible methylphenidate related hoarseness and disturbances of voice quality: Two pediatric cases

Burcu SARI AKIN
Özhan YALÇIN
Aslı ASLAN AKIN
Tümer TÜRKBAY
Pages
278–282
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Dysphonic symptoms in these two children may be related to methylphenidate s direct effects on the central and sympathetic nervous systems.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although methylphenidate is generally a safe drug in children for treatment of attention deficit hyperactivity disorder, it is necessary to monitor carefully its side effects especially on growth and development, the cardiovascular system, appetite and quality of sleep.
📊
Key Findings & Data:In this case report, we present two male children who developed disturbances in voice quality and hoarseness associated with methylphenidate use, which required drug discontinuation.
💡
Conclusion & Impact:Dysphonic symptoms in these two children may be related to methylphenidate s direct effects on the central and sympathetic nervous systems.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Although methylphenidate is generally a safe drug in children for treatment of attention deficit hyperactivity disorder, it is necessary to monitor carefully its side effects especially on growth and development, the cardiovascular system, appetite and quality of sleep. In this case report, we present two male children who developed disturbances in voice quality and hoarseness associated with methylphenidate use, which required drug discontinuation. Dysphonic symptoms in these two children may be related to methylphenidate s direct effects on the central and sympathetic nervous systems.

Özet

Dikkat eksikliği hiperaktivite bozukluğu tedavisinde kullanılan metilfenidat, çocuklarda genel olarak güvenli bir ilaç olsa da, özellikle büyüme gelişme, kardiyovas- küler sistem, iştah ve uyku kalitesi üzerine olan yan etkilerinin dikkatli takibi gereklidir. Bu olgu sunumunda metilfenidat kullanımı ile ilişkili, ilaç kesimine yol açan ses kalitesinde bozulma, ses kısıklığı geliştiren iki erkek çocuğunu sunmaktayız. Bu iki olgudaki disfonik bulgu- lar, metilfenidatın santral sinir sistemi ve sempatik sinir sistemi üzerine olan direkt etkileri ile ilişkili olabilir.

🔖

Cite This Article

AKIN, B. S., YALÇIN, Ö., AKIN, A. A., TÜRKBAY, T. (2022). Metilfenidat ile olası ilişkili ses kısıklığı ve ses kalitesinde bozulma: İki çocuk olgu. Klinik Psikofarmakoloji Bülteni, Cilt: 22 - Sayı: 3, 278–282. https://ajindex.com/articles/574102

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Polanczyk G, de Lima M, Harta B, Biederman J, Rohde L. The worldwide prevalance of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164(6): 942-8
  2. Ferguson JH. The consensus development panel. National institutes of health consensus development conference statement: diagnosis and treatment of attention deficit/hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry 2000; 39(2): 182-93
  3. Lee J, Grizenko N, Bhat V, Sengupta S, Polotskaia A, Joober R. Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD. BMC Psychiatry 2011; 11: 70
  4. Hamdan AL, Deeb R, Sibai A, Rameh C, Rifai H, Fayyad J. Vocal characteristics in children with attention deficit hyperactivity disorder. J Voice 2007; 23(2): 190-4. 5. eHealthMe: ehealthme.com/ds/methylin/hoarseness+or+changing +voice 6. Baker BM, Blackwell PB. Identification and remediation of pediatric fluency and voice disorders. J Pediatr Health Care 2004; 18(2): 87-94
  5. Carding AN, Roulstone S, Northstone K, ALSPAC study team. The prevalance of childhood dysphonia: a cross sectional study. J Voice 2006; 20(4): 623-30
  6. Faust RA. Childhood voice disorders: ambulatory evaluation and operative diagnosis. Clin Pediatr (Phila) 2003; 42(1): 1-9
  7. Ballas CA, Evans DL, Dingers DF. Psychostimulants in psychiatry: amphetamine, methylphenidate, and modafinil. In textbook of psychopharmacology. Schatzberg AF, Nemeroff CB (editors). 3rd ed Arlington: American psychiatric publishing; 2004. p. 671-84
  8. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-45
  9. Aagaard L, Hansen EH. The occurence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies. Neuropsychiatr Dis Treat 2011; 7: 729-44
  10. Deary V, Miller S. Reconsidering the role of psychosocial factors in functional dysphonia. Curr Opin Otolaryngol Head Neck Surg 2011; 19(3): 150-4
  11. Congologlu A, Turkbay T, Ciyiltepe M, Durukan I, Yuce M. Immediate effect of methylphenidate on vocal acoustic parameters in children attention deficit hyperactivity disorder. Bull Clin Psychopharmacol 2009; 19(4): 365-72. (Turkish
  12. Negrao BL, Bipath P, van der Westhuizen D, Viljoen M. Autonomic correlates at rest and du